WEN LONG: Open Payments
NPI 1225117096 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 14 payments from 7 companies in 2025. Trend: 2023 $28 · 2024 $212 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $124 |
| Gilead Sciences, Inc. | 4 | $101 |
| Boston Scientific Corporation | 1 | $52 |
| Ipsen Biopharmaceuticals, Inc | 1 | $31 |
| Eton Pharmaceuticals, Inc. | 1 | $26 |
| Mirum Pharmaceuticals, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: MAVYRET, TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial), Bylvay, GALZIN, Livmarli, XIFAXAN.
Industry payments across CA — which companies pay providers there.
